CDK8-IN-4
CDK8-IN-4 is an inhibitor of CDK8 extracted from patent WO2014090692A1, compound example 16, with an IC50 of 0.2 nM.
Product Specifications
CAS Number
1613638-82-6
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/_R_-2-__5-_1H-indazol-5-yl_pyridin-3-yl_amino_-2-phenylethanol.html
Purity
99.39
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
OC[C@@H](C1=CC=CC=C1)NC2=CC(C3=CC4=C(NN=C4)C=C3)=CN=C2
Molecular Formula
C20H18N4O
Molecular Weight
330.38
References & Citations
[1]Cheng Z, et al. Novel bi-ring phenyl-pyridines/pyrazines for the treatment of cancer. WO2014090692A1
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2144376-01 0.1 mL
Biotin-Linked Monoclonal Antibody to Calretiulin (CALR)
Sign In for Pricing
View Details MBS2144376-02 0.2 mL
Biotin-Linked Monoclonal Antibody to Calretiulin (CALR)
Sign In for Pricing
View Details